Skip to content
Subscriber Only

Medtronic Manipulated Bone Product Data, Senators Say

Medtronic Inc. ghost-wrote sections of medical papers and paid physician authors hundreds of millions of dollars in “consulting fees” to promote its bone-growth product Infuse, a U.S. Senate investigation found.

Medtronic, the world’s biggest maker of heart-rhythm devices, helped write, edit and shape at least 11 medical journal articles about the product, which is used to spur bone growth after spinal surgery, according to report released today by the Senate Finance Committee.